Development of anti-HIV peptides based on a viral capsid protein.

about

Development of anti-HIV peptides based on a viral capsid protein.

Item

http://www.wikidata.org/entity/Q36080284

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Development of anti-HIV peptides based on a viral capsid protein.

@ast

Development of anti-HIV peptides based on a viral capsid protein.

@en

type

Item

label

Development of anti-HIV peptides based on a viral capsid protein.

@ast

Development of anti-HIV peptides based on a viral capsid protein.

@en

prefLabel

Development of anti-HIV peptides based on a viral capsid protein.

@ast

Development of anti-HIV peptides based on a viral capsid protein.

@en

P1476

Development of anti-HIV peptides based on a viral capsid protein.

@en

P2093

Chie Hashimoto

http://www.w3.org/2001/XMLSchema#string

Daichi Matsumoto

http://www.w3.org/2001/XMLSchema#string

Nami Ohashi

http://www.w3.org/2001/XMLSchema#string

Takaaki Mizuguchi

http://www.w3.org/2001/XMLSchema#string

Tsutomu Murakami

http://www.w3.org/2001/XMLSchema#string

Wataru Nomura

http://www.w3.org/2001/XMLSchema#string

P2860

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV

X-ray structures of the hexameric building block of the HIV capsid.

Atomic-level modelling of the HIV capsid

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highl

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

STRUCTURAL VIROLOGY. X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability.

Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries.

Peptide HIV-1 integrase inhibitors from HIV-1 gene products.

Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.

P31

scholarly article

P356

10.1002/BIP.22920

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Hirokazu Tamamura

Naoki Yamamoto

P577

2016-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27428649

http://www.w3.org/2001/XMLSchema#string